Literature DB >> 2999736

Human mucinous breast carcinomas and their lymph node metastases. A histological review of 247 cases.

B B Rasmussen.   

Abstract

In a histologic reevaluation of 247 primary human mucinous breast carcinomas, 207 tumors fullfilled the criteria for further histopathological evaluation. The criteria for entrance in this survey are that at least 25% of the tumor consists of areas of extracellular mucin with small islands of solid epithelial tumor tissue floating in the mucin, and that the extracellular mucin should comprise at least 33% of the total tumor volume. The 247 carcinomas that have been further evaluated have been subclassified into two groups: "pure" mucinous breast carcinomas that consist solely of tumor tissue with extracellular mucin production (95 tumors), and "mixed" mucinous carcinomas that also contain infiltrating carcinoma without extracellular mucin (112 tumor). A significantly greater number of mixed carcinomas than pure carcinomas have an aggressive growth pattern--as defined by tumor size, adherence to overlying skin/bottom fascie, and primary axillary lymph node metastases. The histogenesis of the mucinous carcinomas is briefly discussed in relation to the present observations and the literature. The importance of clearly distinguishing between the mixed and the pure mucinous carcinomas in the diagnosis of these tumors is emphasized.

Entities:  

Mesh:

Year:  1985        PMID: 2999736     DOI: 10.1016/S0344-0338(85)80110-2

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  10 in total

1.  Concerted contractions of tumour fragments derived from a pure mucoid carcinoma of the breast in vitro.

Authors:  J P van Netten; R L Racca; M J Ashwood-Smith; J Armstrong; C Fletcher; N L Goodchild
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Detection of surface antigens defined by monoclonal antibodies in primary mucinous breast carcinomas. Relation to prognostic factors and recurrence-free survival.

Authors:  B B Rasmussen; C Rose; J Hilkens; J Hilgers
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

3.  Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.

Authors:  Purevsuren Jambal; Melanie M Badtke; J Chuck Harrell; Virginia F Borges; Miriam D Post; Grace E Sollender; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2012-12-18       Impact factor: 4.872

4.  Mucinous Breast Cancer: a Review Study of 5 Year Experience from a Hospital-Based Series of Cases.

Authors:  Adrian Dumitru; Alexandru Procop; Andreea Iliesiu; Mircea Tampa; Luminita Mitrache; Mariana Costache; Maria Sajin; Anca Lazaroiu; Monica Cirstoiu
Journal:  Maedica (Buchar)       Date:  2015-03

5.  The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.

Authors:  Xingtong Zhou; Zhibo Zheng; Yan Li; Weiwei Zhao; Yan Lin; Jieshi Zhang; Qiang Sun
Journal:  BMC Cancer       Date:  2021-05-11       Impact factor: 4.430

6.  Mucoid breast carcinomas: histology and prognosis.

Authors:  I S Fentiman; R R Millis; P Smith; J P Ellul; O Lampejo
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.

Authors:  Jianfei Fu; Lunpo Wu; Mengjie Jiang; Dan Li; Ting Jiang; Zhongwu Hong; Fan Wang; Shuguang Li
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

8.  Severe Bilateral Breast Mucinous Carcinoma with Bilateral Lungs and Cutaneous Metastasis: A Case Report and Literature Review.

Authors:  Rong Pu; Yanchu Li; Xianyong Li
Journal:  Case Rep Oncol Med       Date:  2018-03-06

9.  Evaluation of efficacy of chemotherapy for mucinous carcinoma: a surveillance, epidemiology, and end results cohort study.

Authors:  Hanwen Zhang; Ning Zhang; Yaming Li; Yiran Liang; Qifeng Yang
Journal:  Ther Adv Med Oncol       Date:  2020-12-18       Impact factor: 8.168

10.  Omission of Chemotherapy for the Treatment of Mucinous Breast Cancer: A Nationwide Study from the Korean Breast Cancer Society.

Authors:  Hyung Suk Kim; Jong Uk Lee; Tae Kyung Yoo; Byung Joo Chae; Donghee Son; Yun Jin Kim; Woo Chan Park
Journal:  J Breast Cancer       Date:  2019-09-30       Impact factor: 3.588

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.